Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!
A kind of pharmaceutical composition for treating leukemia and its preparation method
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition, technology of leukemia, applied in the field of medicine
Inactive Publication Date: 2015-09-02
中澳贯虹河北生物医药科技发展有限公司
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0027] In the existing literature and patents, there is no report that the traditional Chinese medicine composition of the present invention, that is, the composition composed of Tongjingcao, Altai Goatia, Serrata serrata, Salon zi, and lapis lazuli, is used to prepare medicines for treating leukemia.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0042] Embodiment 1: pharmaceutical composition and preparation method thereof
[0043] The pharmaceutical composition is composed of the following raw materials in parts by weight: 2 parts of Tongjingcao, 4 parts of Altai Gouwahua, 3 parts of Serrata serrata, 1.5 parts of Salon chinensis, and 5 parts of lapis lazuli
[0044] The preparation method of the pharmaceutical composition: pulverize each raw material through a 120-mesh sieve, mix well, add an appropriate amount of water to form a pill, and dry to obtain.
Embodiment 2
[0045] Embodiment 2: pharmaceutical composition and preparation method thereof
[0046] The pharmaceutical composition is composed of the following raw materials in parts by weight: 1 part of Tongjingcao, 5 parts of Altai Gouwahua, 2 parts of Serrata serrata, 1 part of Salon chinensis, 6 parts of lapis lazuli
[0047] The preparation method of the pharmaceutical composition: pulverize each raw material through an 80-mesh sieve, and mix uniformly to obtain the product.
Embodiment 3
[0048] Embodiment 3: pharmaceutical composition and preparation method thereof
[0049] The pharmaceutical composition is composed of the following crude drugs in parts by weight: 3 parts of Tongjingcao, 3 parts of Altai Gouwahua, 4 parts of Serrata serrata, 2 parts of Salon chinensis and 4 parts of lapis lazuli.
[0050] The preparation method of the pharmaceutical composition: pulverize each raw material through a 200-mesh sieve, mix uniformly, make granules with dilute ethanol, dry, add starch and magnesium stearate, and press into tablets to obtain the product.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention relates to a medicinal composition for treatment of leukemia and its preparation method. The medicinal composition is characterized by being prepared from the following raw material drugs by weight: 1-3 parts of Aleuritopteris argentea Fee, 3-5 parts of Heteropappus altaicus, 2-4 parts of Eritrichium, 1-2 parts of shalongzi, and 4-6 parts of lapis lazuli. The preparation method includes: crushing the raw material drugs, conducting sieving by a sieve of 80-200 meshes, making the materials into pills and the like, or performing extraction preparation. The medicinal composition provided by the invention can enhance NCK, IL-6, IL-2, and IFN-gamma activity, and has good application value for treatment of leukemia.
Description
technical field [0001] The invention belongs to the field of medicine, and relates to a pharmaceutical composition for treating leukemia and a preparation method thereof. Background technique [0002] Leukemia is a malignant tumor of the hematopoietic system, characterized by the progressive and uncontrolled abnormal proliferation of white blood cells and their immature cells, as well as immature red blood cells or megakaryocytes (ie, leukemia cells) in the bone marrow or other hematopoietic tissues, infiltrating the whole body Various tissues and organs, and enter the peripheral blood. According to the degree of leukemia cell maturity and the natural process of leukemia, leukemia can be divided into two categories: acute leukemia and chronic leukemia. Acute leukemia has a sudden onset, and symptoms such as anemia, hemorrhage, secondary infection, and fever are caused by the reduction of normal red blood cells. In addition, due to the extensive infiltration of leukemia cel...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.